Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- IPD.AU
- Price
- 0.05
- Stock movement down
- -0.00 (-1.89%)
- Company name
- Impedimed Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 105.23M
- Ent value
- 86.84M
- Price/Sales
- 5.58
- Price/Book
- 2.58
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -30.49%
- 1 year return
- -65.33%
- 3 year return
- -33.89%
- 5 year return
- -21.55%
- 10 year return
- -23.93%
Last updated: 2025-01-07
DIVIDENDS
IPD.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.58 |
| Price to Book | 2.58 |
| EV to Sales | 4.61 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.02B |
| EPS (TTM) | -0.02 |
| FCF per share (TTM) | -0.02 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 18.85M |
| Gross profit (TTM) | -6.91M |
| Operating income (TTM) | -17.35M |
| Net income (TTM) | -34.39M |
| EPS (TTM) | -0.02 |
| EPS (1y forward) | -0.01 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -36.66% |
| Operating margin (TTM) | -92.02% |
| Profit margin (TTM) | -182.39% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.63M |
| Net receivables | 2.19M |
| Total current assets | 29.46M |
| Goodwill | 2.72M |
| Intangible assets | 13.31M |
| Property, plant and equipment | 5.66M |
| Total assets | 46.99M |
| Accounts payable | 1.10M |
| Short/Current long term debt | 1.14M |
| Total current liabilities | 4.66M |
| Total liabilities | 6.24M |
| Shareholder's equity | 40.74M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -26.57M |
| Capital expenditures (TTM) | 6.55M |
| Free cash flow (TTM) | -33.12M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -84.40% |
| Return on Assets | -73.18% |
| Return on Invested Capital | -83.71% |
| Cash Return on Invested Capital | -80.64% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.05 |
| Daily high | 0.05 |
| Daily low | 0.05 |
| Daily Volume | 652K |
| All-time high | 1.74 |
| 1y analyst estimate | 0.15 |
| Beta | 2.87 |
| EPS (TTM) | -0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 25 Feb 2025 |
Downside potential
Loading...
Downside potential data
| IPD.AU | S&P500 | |
| Current price drop from All-time high | -97.01% | -2.05% |
| Highest price drop | -98.05% | -56.47% |
| Date of highest drop | 15 Apr 2020 | 9 Mar 2009 |
| Avg drop from high | -62.08% | -11.12% |
| Avg time to new high | 122 days | 12 days |
| Max time to new high | 2124 days | 1805 days |
COMPANY DETAILS
Marketcap
105.23M
Marketcap category
Small-cap
Description
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.
Employees
83
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found